A detailed history of Gulf International Bank (Uk) LTD transactions in Pfizer Inc stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 440,963 shares of PFE stock, worth $12.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
440,963
Previous 460,470 4.24%
Holding current value
$12.1 Million
Previous $12.9 Million 0.95%
% of portfolio
0.33%
Previous 0.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $540,343 - $612,324
-19,507 Reduced 4.24%
440,963 $12.8 Million
Q2 2024

Jul 10, 2024

SELL
$25.26 - $29.6 $897,108 - $1.05 Million
-35,515 Reduced 7.16%
460,470 $12.9 Million
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $59,935 - $68,824
2,315 Added 0.47%
495,985 $13.8 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $1.1 Million - $1.42 Million
-41,918 Reduced 7.83%
493,670 $14.2 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $1.91 Million - $2.23 Million
-59,379 Reduced 9.98%
535,588 $17.8 Million
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $6.11 Million - $7.07 Million
-169,291 Reduced 22.15%
594,967 $21.8 Million
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $8.01 Million - $10.4 Million
-203,226 Reduced 21.01%
764,258 $31.2 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $181,111 - $236,421
-4,338 Reduced 0.45%
967,484 $49.6 Million
Q3 2022

Oct 07, 2022

BUY
$43.76 - $53.42 $1.38 Million - $1.69 Million
31,543 Added 3.35%
971,822 $42.5 Million
Q2 2022

Jul 19, 2022

BUY
$46.53 - $55.17 $143,312 - $169,923
3,080 Added 0.33%
940,279 $47.9 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $13,725 - $17,007
-300 Reduced 0.03%
937,199 $48.5 Million
Q4 2021

Jan 24, 2022

SELL
$41.32 - $61.25 $7.85 Million - $11.6 Million
-189,932 Reduced 16.85%
937,499 $55.4 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $465,701 - $598,233
-11,865 Reduced 1.04%
1,127,431 $48.5 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $941,380 - $1.07 Million
26,215 Added 2.36%
1,139,296 $44.6 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $4.21 Million - $4.74 Million
-125,621 Reduced 10.14%
1,113,081 $40.3 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $3.81 Million - $4.85 Million
-113,952 Reduced 8.42%
1,238,702 $45.6 Million
Q3 2020

Oct 21, 2020

SELL
$31.75 - $37.25 $279,273 - $327,651
-8,796 Reduced 0.65%
1,352,654 $49.6 Million
Q2 2020

Jul 24, 2020

BUY
$30.12 - $36.54 $466,950 - $566,479
15,503 Added 1.15%
1,361,450 $44.5 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $386,772 - $552,613
14,309 Added 1.07%
1,345,947 $43.9 Million
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $85,592 - $97,136
-2,600 Reduced 0.19%
1,331,638 $52.2 Million
Q3 2019

Oct 08, 2019

SELL
$32.49 - $42.13 $42,886 - $55,611
-1,320 Reduced 0.1%
1,334,238 $47.9 Million
Q2 2019

Jul 10, 2019

SELL
$36.98 - $41.52 $2.49 Million - $2.79 Million
-67,226 Reduced 4.79%
1,335,558 $57.9 Million
Q1 2019

Apr 18, 2019

SELL
$37.5 - $41.2 $48,000 - $52,736
-1,280 Reduced 0.09%
1,402,784 $59.6 Million
Q4 2018

Jan 08, 2019

SELL
$38.47 - $43.86 $23 Million - $26.3 Million
-599,152 Reduced 29.91%
1,404,064 $61.3 Million
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $2.94 Million - $3.57 Million
85,324 Added 4.45%
2,003,216 $88.3 Million
Q2 2018

Jul 05, 2018

BUY
$32.98 - $35.16 $1.34 Million - $1.43 Million
40,534 Added 2.16%
1,917,892 $69.6 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $414,447 - $480,815
-12,988 Reduced 0.69%
1,877,358 $66.6 Million
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $58.6 Million - $64.6 Million
1,890,346
1,890,346 $67.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.